National Centre for Pharmacoeconomics

National Centre for
Pharmacoeconomics

NCPE Ireland

Asenapine (Sycrest®) for the treatment of moderate to severe manic episodes associated with biopolar 1 disorder in adults.

Rapid Review

Commenced Completed Outcome
17/08/2011 06/09/2011 Full Pharmacoeconomic Evaluation not Recommended.